Finnish Perspective on Drug-Impaired Driving Finds Cannabis Among Top Substances Detected | Research

The takeaway

Review of drug-impaired driving policies and data across Europe found illicit drug prevalence of 1-5% among general drivers, with cannabis, amphetamines, benzodiazepines, and opiates among the most concerning substances for driving safety.

Read this if you want to understand the challenges of detecting and enforcing drug-impaired driving, particularly for cannabis.

1-5% of European drivers tested positive for illicit drugs; 5-10% for licit drugs affecting driving

What the researchers found

This review examined drug-impaired driving from a Finnish and European perspective. It reported that the prevalence of illicit drug use among the general driving population in Europe ranged from 1-5%, while licit drugs affecting driving (particularly benzodiazepines) had a prevalence of 5-10%.

Drugs identified as most concerning for driving impairment included amphetamines, cocaine, cannabis, opiates, and benzodiazepines. The review discussed evolving legal frameworks, noting that some countries had introduced zero-tolerance per se laws that prohibit driving with any detectable level of illicit drugs or metabolites, regardless of demonstrated impairment.

The review also discussed advancing roadside testing technology, including oral fluid (saliva) testing. Legislation in Victoria, Australia already allowed oral fluid testing for cannabis and methamphetamine, though blood testing remained the most common form of evidentiary testing in most jurisdictions.

Why it matters

As cannabis legalization has expanded since this review, the question of drug-impaired driving has become increasingly important. The distinction between zero-tolerance approaches (any detectable level) and impairment-based approaches (demonstrated functional impairment) remains a central policy debate.

The numbers in context

Illicit drug prevalence in European general driving population: 1-5%. Licit drug prevalence affecting driving: 5-10%. Most concerning drugs: amphetamines, cocaine, cannabis, opiates, benzodiazepines. Some countries adopted zero-tolerance per se laws.

How the study worked

Review article examining drug-impaired driving from a Finnish perspective, covering prevalence data, legal frameworks across countries, detection methods (blood, oral fluid, urine), and enforcement approaches. Drew on epidemiological data from drivers, offenders, and crash-involved populations.

What this study cannot tell us

The review focused on the Finnish and European context, which may not generalize to other regions. Data on drug prevalence among drivers varied in quality across countries. The review did not establish specific impairment thresholds for individual drugs.

How to read the evidence

Review article compiling epidemiological data and policy analysis from multiple European countries. Provides a broad overview but limited by varying data quality across jurisdictions.

When this study was published

Published in 2005. Drug-impaired driving detection technology and legislation have evolved substantially since then, particularly as cannabis legalization has expanded.

The bigger picture

The debate over how to define and enforce drug-impaired driving has only intensified as more jurisdictions legalize cannabis. The fundamental challenge remains: unlike alcohol, there is no established relationship between blood THC levels and degree of driving impairment, making per se limits controversial.

Questions still open

Can roadside testing technology reliably detect cannabis impairment as opposed to mere recent use? Is a zero-tolerance approach or an impairment-based approach more effective for cannabis-impaired driving enforcement?

Common questions

How common is drug-impaired driving?

This review estimated 1-5% of European general population drivers tested positive for illicit drugs, with another 5-10% positive for licit drugs that affect driving ability (primarily benzodiazepines). Rates were higher among those involved in crashes or suspected of impaired driving.

Can police test for cannabis at the roadside?

As of 2005, some jurisdictions (notably Victoria, Australia) had implemented oral fluid roadside testing for cannabis. Most countries still relied on blood testing for evidentiary purposes. Roadside detection technology has continued to advance since then.

Read the original research

Drugs and driving: the Finnish perspective.

Bulletin on narcotics, 57(1-2), 213-29

View on PubMed ↗

Citation

Lillsunde, P; Gunnar, T. (2005). Drugs and driving: the Finnish perspective.. Bulletin on narcotics, 57(1-2), 213-29.